Selected research
Industry Research
Drugs of Abuse Analysis Controls Industry Research Report 2026
Market perspective
The global Drugs of Abuse Analysis Controls market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Drugs of Abuse Analysis Controls is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Drugs of Abuse Analysis Controls is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Drugs of Abuse Analysis Controls is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Drugs of Abuse Analysis Controls include American Bio Medica Corp, Bio-Rad Laboratories, BTNX, Carolina Liquid Chemistries, Cerilliant, Clarity Diagnostics LLC, Diatron, JAS Diagnostics and Kova International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Drugs of Abuse Analysis Controls market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Drugs of Abuse Analysis Controls Market by Company
American Bio Medica Corp
Bio-Rad Laboratories
BTNX
Carolina Liquid Chemistries
Cerilliant
Clarity Diagnostics LLC
Diatron
JAS Diagnostics
Kova International
Lin-Zhi International Inc
MedTest DX
Microgenics
Ortho Clinical Diagnostics
Quasar Instruments
QuidelOrtho Corporation
Beckman Coulter
Horiba
Thermo Fisher Scientific
Siemens
Abbott
Drugs of Abuse Analysis Controls Segment by Type
Liquid
Lyophilized
Others
Drugs of Abuse Analysis Controls Segment by Application
Clinical
Diagnostic Laboratories
Hospital
Others
Drugs of Abuse Analysis Controls Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs of Abuse Analysis Controls market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drugs of Abuse Analysis Controls and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs of Abuse Analysis Controls.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Drugs of Abuse Analysis Controls manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Drugs of Abuse Analysis Controls by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Drugs of Abuse Analysis Controls in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Drugs of Abuse Analysis Controls Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Drugs of Abuse Analysis Controls Sales (k units) of Manufacturers (2021-2026)
Table 7. Global Drugs of Abuse Analysis Controls Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Drugs of Abuse Analysis Controls Revenue of Manufacturers (2021-2026)
Table 9. Global Drugs of Abuse Analysis Controls Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Drugs of Abuse Analysis Controls Average Price (USD/unit) of Manufacturers (2021-2026)
Table 11. Global Drugs of Abuse Analysis Controls Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Drugs of Abuse Analysis Controls, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Drugs of Abuse Analysis Controls, Product Type & Application
Table 14. Global Drugs of Abuse Analysis Controls Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Drugs of Abuse Analysis Controls by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. American Bio Medica Corp Company Information
Table 19. American Bio Medica Corp Business Overview
Table 20. American Bio Medica Corp Drugs of Abuse Analysis Controls Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 21. American Bio Medica Corp Drugs of Abuse Analysis Controls Product Portfolio
Table 22. American Bio Medica Corp Recent Developments
Table 23. Bio-Rad Laboratories Company Information
Table 24. Bio-Rad Laboratories Business Overview
Table 25. Bio-Rad Laboratories Drugs of Abuse Analysis Controls Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 26. Bio-Rad Laboratories Drugs of Abuse Analysis Controls Product Portfolio
Table 27. Bio-Rad Laboratories Recent Developments
Table 28. BTNX Company Information
Table 29. BTNX Business Overview
Table 30. BTNX Drugs of Abuse Analysis Controls Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 31. BTNX Drugs of Abuse Analysis Controls Product Portfolio
Table 32. BTNX Recent Developments
Table 33. Carolina Liquid Chemistries Company Information
Table 34. Carolina Liquid Chemistries Business Overview
Table 35. Carolina Liquid Chemistries Drugs of Abuse Analysis Controls Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 36. Carolina Liquid Chemistries Drugs of Abuse Analysis Controls Product Portfolio
Table 37. Carolina Liquid Chemistries Recent Developments
Table 38. Cerilliant Company Information
Table 39. Cerilliant Business Overview
Table 40. Cerilliant Drugs of Abuse Analysis Controls Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 41. Cerilliant Drugs of Abuse Analysis Controls Product Portfolio
Table 42. Cerilliant Recent Developments
Table 43. Clarity Diagnostics LLC Company Information
Table 44. Clarity Diagnostics LLC Business Overview
Table 45. Clarity Diagnostics LLC Drugs of Abuse Analysis Controls Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 46. Clarity Diagnostics LLC Drugs of Abuse Analysis Controls Product Portfolio
Table 47. Clarity Diagnostics LLC Recent Developments
Table 48. Diatron Company Information
Table 49. Diatron Business Overview
Table 50. Diatron Drugs of Abuse Analysis Controls Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 51. Diatron Drugs of Abuse Analysis Controls Product Portfolio
Table 52. Diatron Recent Developments
Table 53. JAS Diagnostics Company Information
Table 54. JAS Diagnostics Business Overview
Table 55. JAS Diagnostics Drugs of Abuse Analysis Controls Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 56. JAS Diagnostics Drugs of Abuse Analysis Controls Product Portfolio
Table 57. JAS Diagnostics Recent Developments
Table 58. Kova International Company Information
Table 59. Kova International Business Overview
Table 60. Kova International Drugs of Abuse Analysis Controls Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 61. Kova International Drugs of Abuse Analysis Controls Product Portfolio
Table 62. Kova International Recent Developments
Table 63. Lin-Zhi International Inc Company Information
Table 64. Lin-Zhi International Inc Business Overview
Table 65. Lin-Zhi International Inc Drugs of Abuse Analysis Controls Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 66. Lin-Zhi International Inc Drugs of Abuse Analysis Controls Product Portfolio
Table 67. Lin-Zhi International Inc Recent Developments
Table 68. MedTest DX Company Information
Table 69. MedTest DX Business Overview
Table 70. MedTest DX Drugs of Abuse Analysis Controls Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 71. MedTest DX Drugs of Abuse Analysis Controls Product Portfolio
Table 72. MedTest DX Recent Developments
Table 73. Microgenics Company Information
Table 74. Microgenics Business Overview
Table 75. Microgenics Drugs of Abuse Analysis Controls Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 76. Microgenics Drugs of Abuse Analysis Controls Product Portfolio
Table 77. Microgenics Recent Developments
Table 78. Ortho Clinical Diagnostics Company Information
Table 79. Ortho Clinical Diagnostics Business Overview
Table 80. Ortho Clinical Diagnostics Drugs of Abuse Analysis Controls Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 81. Ortho Clinical Diagnostics Drugs of Abuse Analysis Controls Product Portfolio
Table 82. Ortho Clinical Diagnostics Recent Developments
Table 83. Quasar Instruments Company Information
Table 84. Quasar Instruments Business Overview
Table 85. Quasar Instruments Drugs of Abuse Analysis Controls Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 86. Quasar Instruments Drugs of Abuse Analysis Controls Product Portfolio
Table 87. Quasar Instruments Recent Developments
Table 88. QuidelOrtho Corporation Company Information
Table 89. QuidelOrtho Corporation Business Overview
Table 90. QuidelOrtho Corporation Drugs of Abuse Analysis Controls Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 91. QuidelOrtho Corporation Drugs of Abuse Analysis Controls Product Portfolio
Table 92. QuidelOrtho Corporation Recent Developments
Table 93. Beckman Coulter Company Information
Table 94. Beckman Coulter Business Overview
Table 95. Beckman Coulter Drugs of Abuse Analysis Controls Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 96. Beckman Coulter Drugs of Abuse Analysis Controls Product Portfolio
Table 97. Beckman Coulter Recent Developments
Table 98. Horiba Company Information
Table 99. Horiba Business Overview
Table 100. Horiba Drugs of Abuse Analysis Controls Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 101. Horiba Drugs of Abuse Analysis Controls Product Portfolio
Table 102. Horiba Recent Developments
Table 103. Thermo Fisher Scientific Company Information
Table 104. Thermo Fisher Scientific Business Overview
Table 105. Thermo Fisher Scientific Drugs of Abuse Analysis Controls Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 106. Thermo Fisher Scientific Drugs of Abuse Analysis Controls Product Portfolio
Table 107. Thermo Fisher Scientific Recent Developments
Table 108. Siemens Company Information
Table 109. Siemens Business Overview
Table 110. Siemens Drugs of Abuse Analysis Controls Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 111. Siemens Drugs of Abuse Analysis Controls Product Portfolio
Table 112. Siemens Recent Developments
Table 113. Abbott Company Information
Table 114. Abbott Business Overview
Table 115. Abbott Drugs of Abuse Analysis Controls Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 116. Abbott Drugs of Abuse Analysis Controls Product Portfolio
Table 117. Abbott Recent Developments
Table 118. Global Drugs of Abuse Analysis Controls Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 119. Global Drugs of Abuse Analysis Controls Sales by Region (2021-2026) & (k units)
Table 120. Global Drugs of Abuse Analysis Controls Sales Market Share by Region (2021-2026)
Table 121. Global Drugs of Abuse Analysis Controls Sales by Region (2027-2032) & (k units)
Table 122. Global Drugs of Abuse Analysis Controls Sales Market Share by Region (2027-2032)
Table 123. Global Drugs of Abuse Analysis Controls Revenue by Region (2021-2026) & (US$ Million)
Table 124. Global Drugs of Abuse Analysis Controls Revenue Market Share by Region (2021-2026)
Table 125. Global Drugs of Abuse Analysis Controls Revenue by Region (2027-2032) & (US$ Million)
Table 126. Global Drugs of Abuse Analysis Controls Revenue Market Share by Region (2027-2032)
Table 127. North America Drugs of Abuse Analysis Controls Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 128. North America Drugs of Abuse Analysis Controls Sales by Country (2021-2026) & (k units)
Table 129. North America Drugs of Abuse Analysis Controls Sales by Country (2027-2032) & (k units)
Table 130. North America Drugs of Abuse Analysis Controls Revenue by Country (2021-2026) & (US$ Million)
Table 131. North America Drugs of Abuse Analysis Controls Revenue by Country (2027-2032) & (US$ Million)
Table 132. Europe Drugs of Abuse Analysis Controls Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 133. Europe Drugs of Abuse Analysis Controls Sales by Country (2021-2026) & (k units)
Table 134. Europe Drugs of Abuse Analysis Controls Sales by Country (2027-2032) & (k units)
Table 135. Europe Drugs of Abuse Analysis Controls Revenue by Country (2021-2026) & (US$ Million)
Table 136. Europe Drugs of Abuse Analysis Controls Revenue by Country (2027-2032) & (US$ Million)
Table 137. Asia Pacific Drugs of Abuse Analysis Controls Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 138. Asia Pacific Drugs of Abuse Analysis Controls Sales by Country (2021-2026) & (k units)
Table 139. Asia Pacific Drugs of Abuse Analysis Controls Sales by Country (2027-2032) & (k units)
Table 140. Asia Pacific Drugs of Abuse Analysis Controls Revenue by Country (2021-2026) & (US$ Million)
Table 141. Asia Pacific Drugs of Abuse Analysis Controls Revenue by Country (2027-2032) & (US$ Million)
Table 142. South America Drugs of Abuse Analysis Controls Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 143. South America Drugs of Abuse Analysis Controls Sales by Country (2021-2026) & (k units)
Table 144. South America Drugs of Abuse Analysis Controls Sales by Country (2027-2032) & (k units)
Table 145. South America Drugs of Abuse Analysis Controls Revenue by Country (2021-2026) & (US$ Million)
Table 146. South America Drugs of Abuse Analysis Controls Revenue by Country (2027-2032) & (US$ Million)
Table 147. Middle East and Africa Drugs of Abuse Analysis Controls Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 148. Middle East and Africa Drugs of Abuse Analysis Controls Sales by Country (2021-2026) & (k units)
Table 149. Middle East and Africa Drugs of Abuse Analysis Controls Sales by Country (2027-2032) & (k units)
Table 150. Middle East and Africa Drugs of Abuse Analysis Controls Revenue by Country (2021-2026) & (US$ Million)
Table 151. Middle East and Africa Drugs of Abuse Analysis Controls Revenue by Country (2027-2032) & (US$ Million)
Table 152. Global Drugs of Abuse Analysis Controls Sales by Type (2021-2026) & (k units)
Table 153. Global Drugs of Abuse Analysis Controls Sales by Type (2027-2032) & (k units)
Table 154. Global Drugs of Abuse Analysis Controls Sales Market Share by Type (2021-2026)
Table 155. Global Drugs of Abuse Analysis Controls Sales Market Share by Type (2027-2032)
Table 156. Global Drugs of Abuse Analysis Controls Revenue by Type (2021-2026) & (US$ Million)
Table 157. Global Drugs of Abuse Analysis Controls Revenue by Type (2027-2032) & (US$ Million)
Table 158. Global Drugs of Abuse Analysis Controls Revenue Market Share by Type (2021-2026)
Table 159. Global Drugs of Abuse Analysis Controls Revenue Market Share by Type (2027-2032)
Table 160. Global Drugs of Abuse Analysis Controls Price by Type (2021-2026) & (USD/unit)
Table 161. Global Drugs of Abuse Analysis Controls Price by Type (2027-2032) & (USD/unit)
Table 162. Global Drugs of Abuse Analysis Controls Sales by Application (2021-2026) & (k units)
Table 163. Global Drugs of Abuse Analysis Controls Sales by Application (2027-2032) & (k units)
Table 164. Global Drugs of Abuse Analysis Controls Sales Market Share by Application (2021-2026)
Table 165. Global Drugs of Abuse Analysis Controls Sales Market Share by Application (2027-2032)
Table 166. Global Drugs of Abuse Analysis Controls Revenue by Application (2021-2026) & (US$ Million)
Table 167. Global Drugs of Abuse Analysis Controls Revenue by Application (2027-2032) & (US$ Million)
Table 168. Global Drugs of Abuse Analysis Controls Revenue Market Share by Application (2021-2026)
Table 169. Global Drugs of Abuse Analysis Controls Revenue Market Share by Application (2027-2032)
Table 170. Global Drugs of Abuse Analysis Controls Price by Application (2021-2026) & (USD/unit)
Table 171. Global Drugs of Abuse Analysis Controls Price by Application (2027-2032) & (USD/unit)
Table 172. Key Raw Materials
Table 173. Raw Materials Key Suppliers
Table 174. Drugs of Abuse Analysis Controls Distributors List
Table 175. Drugs of Abuse Analysis Controls Customers List
Table 176. Drugs of Abuse Analysis Controls Industry Trends
Table 177. Drugs of Abuse Analysis Controls Industry Drivers
Table 178. Drugs of Abuse Analysis Controls Industry Restraints
Table 179. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Drugs of Abuse Analysis Controls Product Image
Figure 5. Global Drugs of Abuse Analysis Controls Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Drugs of Abuse Analysis Controls Market Size (2021-2032) & (US$ Million)
Figure 7. Global Drugs of Abuse Analysis Controls Sales (2021-2032) & (k units)
Figure 8. Global Drugs of Abuse Analysis Controls Average Price (USD/unit) & (2021-2032)
Figure 9. Liquid Product Image
Figure 10. Lyophilized Product Image
Figure 11. Others Product Image
Figure 12. Clinical Product Image
Figure 13. Diagnostic Laboratories Product Image
Figure 14. Hospital Product Image
Figure 15. Others Product Image
Figure 16. Global Drugs of Abuse Analysis Controls Revenue Share by Manufacturers in 2025
Figure 17. Global Manufacturers of Drugs of Abuse Analysis Controls, Manufacturing Sites & Headquarters
Figure 18. Global Top 5 and 10 Drugs of Abuse Analysis Controls Players Market Share by Revenue in 2025
Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 20. Global Drugs of Abuse Analysis Controls Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 21. Global Drugs of Abuse Analysis Controls Sales by Region in 2025
Figure 22. Global Drugs of Abuse Analysis Controls Revenue by Region in 2025
Figure 23. North America Drugs of Abuse Analysis Controls Market Size by Country in 2025
Figure 24. North America Drugs of Abuse Analysis Controls Sales Market Share by Country (2021-2032)
Figure 25. North America Drugs of Abuse Analysis Controls Revenue Market Share by Country (2021-2032)
Figure 26. United States Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Canada Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 28. Mexico Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 29. Europe Drugs of Abuse Analysis Controls Market Size by Country in 2025
Figure 30. Europe Drugs of Abuse Analysis Controls Sales Market Share by Country (2021-2032)
Figure 31. Europe Drugs of Abuse Analysis Controls Revenue Market Share by Country (2021-2032)
Figure 32. Germany Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. France Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. U.K. Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Italy Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Russia Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Spain Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Netherlands Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Switzerland Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Sweden Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Poland Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. Asia Pacific Drugs of Abuse Analysis Controls Market Size by Country in 2025
Figure 43. Asia Pacific Drugs of Abuse Analysis Controls Sales Market Share by Country (2021-2032)
Figure 44. Asia Pacific Drugs of Abuse Analysis Controls Revenue Market Share by Country (2021-2032)
Figure 45. China Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. Japan Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. South Korea Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. India Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Australia Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Taiwan Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Southeast Asia Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. Southeast Asia Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 53. South America Drugs of Abuse Analysis Controls Market Size by Country in 2025
Figure 54. South America Drugs of Abuse Analysis Controls Sales Market Share by Country (2021-2032)
Figure 55. South America Drugs of Abuse Analysis Controls Revenue Market Share by Country (2021-2032)
Figure 56. Brazil Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Argentina Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. Chile Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 59. Middle East and Africa Drugs of Abuse Analysis Controls Market Size by Country in 2025
Figure 60. Middle East and Africa Drugs of Abuse Analysis Controls Sales Market Share by Country (2021-2032)
Figure 61. Middle East and Africa Drugs of Abuse Analysis Controls Revenue Market Share by Country (2021-2032)
Figure 62. Egypt Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. South Africa Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. Israel Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 65. Türkiye Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 66. GCC Countries Drugs of Abuse Analysis Controls Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 67. Global Drugs of Abuse Analysis Controls Sales Market Share by Type (2021-2032)
Figure 68. Global Drugs of Abuse Analysis Controls Revenue Market Share by Type (2021-2032)
Figure 69. Global Drugs of Abuse Analysis Controls Price (USD/unit) by Type (2021-2032)
Figure 70. Global Drugs of Abuse Analysis Controls Sales Market Share by Application (2021-2032)
Figure 71. Global Drugs of Abuse Analysis Controls Revenue Market Share by Application (2021-2032)
Figure 72. Global Drugs of Abuse Analysis Controls Price (USD/unit) by Application (2021-2032)
Figure 73. Drugs of Abuse Analysis Controls Value Chain
Figure 74. Drugs of Abuse Analysis Controls Production Mode & Process
Figure 75. Direct Comparison with Distribution Share
Figure 76. Distributors Profiles
Figure 77. Drugs of Abuse Analysis Controls Industry Opportunities and Challenges
Scope & coverage.
Types
- Liquid
- Lyophilized
- Others
Applications
- Clinical
- Diagnostic Laboratories
- Hospital
- Others
Companies covered
- American Bio Medica Corp
- Bio-Rad Laboratories
- BTNX
- Carolina Liquid Chemistries
- Cerilliant
- Clarity Diagnostics LLC
- Diatron
- JAS Diagnostics
- Kova International
- Lin-Zhi International Inc
- MedTest DX
- Microgenics
- Ortho Clinical Diagnostics
- Quasar Instruments
- QuidelOrtho Corporation
- Beckman Coulter
- Horiba
- Thermo Fisher Scientific
- Siemens
- Abbott
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Drugs of Abuse Analysis Controls Market Size (2021-2032)
- 2.2.2 Global Drugs of Abuse Analysis Controls Sales (2021-2032)
- 2.2.3 Global Drugs of Abuse Analysis Controls Market Average Price (2021-2032)
- 2.3 Drugs of Abuse Analysis Controls by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Liquid
- 2.3.3 Lyophilized
- 2.3.4 Others
- 2.4 Drugs of Abuse Analysis Controls by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinical
- 2.4.3 Diagnostic Laboratories
- 2.4.4 Hospital
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Drugs of Abuse Analysis Controls Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Drugs of Abuse Analysis Controls Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Drugs of Abuse Analysis Controls Revenue of Manufacturers (2021-2026)
- 3.4 Global Drugs of Abuse Analysis Controls Average Price by Manufacturers (2021-2026)
- 3.5 Global Drugs of Abuse Analysis Controls Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Drugs of Abuse Analysis Controls, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Drugs of Abuse Analysis Controls, Product Type & Application
- 3.8 Global Manufacturers of Drugs of Abuse Analysis Controls, Established Date
- 3.9 Global Drugs of Abuse Analysis Controls Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 American Bio Medica Corp
- 4.1.1 American Bio Medica Corp Company Information
- 4.1.2 American Bio Medica Corp Business Overview
- 4.1.3 American Bio Medica Corp Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 American Bio Medica Corp Drugs of Abuse Analysis Controls Product Portfolio
- 4.1.5 American Bio Medica Corp Recent Developments
- 4.2 Bio-Rad Laboratories
- 4.2.1 Bio-Rad Laboratories Company Information
- 4.2.2 Bio-Rad Laboratories Business Overview
- 4.2.3 Bio-Rad Laboratories Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bio-Rad Laboratories Drugs of Abuse Analysis Controls Product Portfolio
- 4.2.5 Bio-Rad Laboratories Recent Developments
- 4.3 BTNX
- 4.3.1 BTNX Company Information
- 4.3.2 BTNX Business Overview
- 4.3.3 BTNX Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 BTNX Drugs of Abuse Analysis Controls Product Portfolio
- 4.3.5 BTNX Recent Developments
- 4.4 Carolina Liquid Chemistries
- 4.4.1 Carolina Liquid Chemistries Company Information
- 4.4.2 Carolina Liquid Chemistries Business Overview
- 4.4.3 Carolina Liquid Chemistries Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Carolina Liquid Chemistries Drugs of Abuse Analysis Controls Product Portfolio
- 4.4.5 Carolina Liquid Chemistries Recent Developments
- 4.5 Cerilliant
- 4.5.1 Cerilliant Company Information
- 4.5.2 Cerilliant Business Overview
- 4.5.3 Cerilliant Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Cerilliant Drugs of Abuse Analysis Controls Product Portfolio
- 4.5.5 Cerilliant Recent Developments
- 4.6 Clarity Diagnostics LLC
- 4.6.1 Clarity Diagnostics LLC Company Information
- 4.6.2 Clarity Diagnostics LLC Business Overview
- 4.6.3 Clarity Diagnostics LLC Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Clarity Diagnostics LLC Drugs of Abuse Analysis Controls Product Portfolio
- 4.6.5 Clarity Diagnostics LLC Recent Developments
- 4.7 Diatron
- 4.7.1 Diatron Company Information
- 4.7.2 Diatron Business Overview
- 4.7.3 Diatron Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Diatron Drugs of Abuse Analysis Controls Product Portfolio
- 4.7.5 Diatron Recent Developments
- 4.8 JAS Diagnostics
- 4.8.1 JAS Diagnostics Company Information
- 4.8.2 JAS Diagnostics Business Overview
- 4.8.3 JAS Diagnostics Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 JAS Diagnostics Drugs of Abuse Analysis Controls Product Portfolio
- 4.8.5 JAS Diagnostics Recent Developments
- 4.9 Kova International
- 4.9.1 Kova International Company Information
- 4.9.2 Kova International Business Overview
- 4.9.3 Kova International Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Kova International Drugs of Abuse Analysis Controls Product Portfolio
- 4.9.5 Kova International Recent Developments
- 4.10 Lin-Zhi International Inc
- 4.10.1 Lin-Zhi International Inc Company Information
- 4.10.2 Lin-Zhi International Inc Business Overview
- 4.10.3 Lin-Zhi International Inc Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Lin-Zhi International Inc Drugs of Abuse Analysis Controls Product Portfolio
- 4.10.5 Lin-Zhi International Inc Recent Developments
- 4.11 MedTest DX
- 4.11.1 MedTest DX Company Information
- 4.11.2 MedTest DX Business Overview
- 4.11.3 MedTest DX Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 MedTest DX Drugs of Abuse Analysis Controls Product Portfolio
- 4.11.5 MedTest DX Recent Developments
- 4.12 Microgenics
- 4.12.1 Microgenics Company Information
- 4.12.2 Microgenics Business Overview
- 4.12.3 Microgenics Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Microgenics Drugs of Abuse Analysis Controls Product Portfolio
- 4.12.5 Microgenics Recent Developments
- 4.13 Ortho Clinical Diagnostics
- 4.13.1 Ortho Clinical Diagnostics Company Information
- 4.13.2 Ortho Clinical Diagnostics Business Overview
- 4.13.3 Ortho Clinical Diagnostics Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Ortho Clinical Diagnostics Drugs of Abuse Analysis Controls Product Portfolio
- 4.13.5 Ortho Clinical Diagnostics Recent Developments
- 4.14 Quasar Instruments
- 4.14.1 Quasar Instruments Company Information
- 4.14.2 Quasar Instruments Business Overview
- 4.14.3 Quasar Instruments Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Quasar Instruments Drugs of Abuse Analysis Controls Product Portfolio
- 4.14.5 Quasar Instruments Recent Developments
- 4.15 QuidelOrtho Corporation
- 4.15.1 QuidelOrtho Corporation Company Information
- 4.15.2 QuidelOrtho Corporation Business Overview
- 4.15.3 QuidelOrtho Corporation Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 QuidelOrtho Corporation Drugs of Abuse Analysis Controls Product Portfolio
- 4.15.5 QuidelOrtho Corporation Recent Developments
- 4.16 Beckman Coulter
- 4.16.1 Beckman Coulter Company Information
- 4.16.2 Beckman Coulter Business Overview
- 4.16.3 Beckman Coulter Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Beckman Coulter Drugs of Abuse Analysis Controls Product Portfolio
- 4.16.5 Beckman Coulter Recent Developments
- 4.17 Horiba
- 4.17.1 Horiba Company Information
- 4.17.2 Horiba Business Overview
- 4.17.3 Horiba Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Horiba Drugs of Abuse Analysis Controls Product Portfolio
- 4.17.5 Horiba Recent Developments
- 4.18 Thermo Fisher Scientific
- 4.18.1 Thermo Fisher Scientific Company Information
- 4.18.2 Thermo Fisher Scientific Business Overview
- 4.18.3 Thermo Fisher Scientific Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Thermo Fisher Scientific Drugs of Abuse Analysis Controls Product Portfolio
- 4.18.5 Thermo Fisher Scientific Recent Developments
- 4.19 Siemens
- 4.19.1 Siemens Company Information
- 4.19.2 Siemens Business Overview
- 4.19.3 Siemens Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Siemens Drugs of Abuse Analysis Controls Product Portfolio
- 4.19.5 Siemens Recent Developments
- 4.20 Abbott
- 4.20.1 Abbott Company Information
- 4.20.2 Abbott Business Overview
- 4.20.3 Abbott Drugs of Abuse Analysis Controls Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Abbott Drugs of Abuse Analysis Controls Product Portfolio
- 4.20.5 Abbott Recent Developments
5 Global Drugs of Abuse Analysis Controls Market Scenario by Region
- 5.1 Global Drugs of Abuse Analysis Controls Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Drugs of Abuse Analysis Controls Sales by Region: 2021-2032
- 5.2.1 Global Drugs of Abuse Analysis Controls Sales by Region: 2021-2026
- 5.2.2 Global Drugs of Abuse Analysis Controls Sales by Region: 2027-2032
- 5.3 Global Drugs of Abuse Analysis Controls Revenue by Region: 2021-2032
- 5.3.1 Global Drugs of Abuse Analysis Controls Revenue by Region: 2021-2026
- 5.3.2 Global Drugs of Abuse Analysis Controls Revenue by Region: 2027-2032
- 5.4 North America Drugs of Abuse Analysis Controls Market Facts & Figures by Country
- 5.4.1 North America Drugs of Abuse Analysis Controls Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Drugs of Abuse Analysis Controls Sales by Country (2021-2032)
- 5.4.3 North America Drugs of Abuse Analysis Controls Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Drugs of Abuse Analysis Controls Market Facts & Figures by Country
- 5.5.1 Europe Drugs of Abuse Analysis Controls Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Drugs of Abuse Analysis Controls Sales by Country (2021-2032)
- 5.5.3 Europe Drugs of Abuse Analysis Controls Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Drugs of Abuse Analysis Controls Market Facts & Figures by Country
- 5.6.1 Asia Pacific Drugs of Abuse Analysis Controls Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Drugs of Abuse Analysis Controls Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Drugs of Abuse Analysis Controls Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Drugs of Abuse Analysis Controls Market Facts & Figures by Country
- 5.7.1 South America Drugs of Abuse Analysis Controls Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Drugs of Abuse Analysis Controls Sales by Country (2021-2032)
- 5.7.3 South America Drugs of Abuse Analysis Controls Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Drugs of Abuse Analysis Controls Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Drugs of Abuse Analysis Controls Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Drugs of Abuse Analysis Controls Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Drugs of Abuse Analysis Controls Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Drugs of Abuse Analysis Controls Sales by Type (2021-2032)
- 6.1.1 Global Drugs of Abuse Analysis Controls Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Drugs of Abuse Analysis Controls Sales Market Share by Type (2021-2032)
- 6.2 Global Drugs of Abuse Analysis Controls Revenue by Type (2021-2032)
- 6.2.1 Global Drugs of Abuse Analysis Controls Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Drugs of Abuse Analysis Controls Revenue Market Share by Type (2021-2032)
- 6.3 Global Drugs of Abuse Analysis Controls Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Drugs of Abuse Analysis Controls Sales by Application (2021-2032)
- 7.1.1 Global Drugs of Abuse Analysis Controls Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Drugs of Abuse Analysis Controls Sales Market Share by Application (2021-2032)
- 7.2 Global Drugs of Abuse Analysis Controls Revenue by Application (2021-2032)
- 7.2.1 Global Drugs of Abuse Analysis Controls Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Drugs of Abuse Analysis Controls Revenue Market Share by Application (2021-2032)
- 7.3 Global Drugs of Abuse Analysis Controls Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Drugs of Abuse Analysis Controls Value Chain Analysis
- 8.1.1 Drugs of Abuse Analysis Controls Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Drugs of Abuse Analysis Controls Production Mode & Process
- 8.2 Drugs of Abuse Analysis Controls Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Drugs of Abuse Analysis Controls Distributors
- 8.2.3 Drugs of Abuse Analysis Controls Customers
9 Global Drugs of Abuse Analysis Controls Analyzing Market Dynamics
- 9.1 Drugs of Abuse Analysis Controls Industry Trends
- 9.2 Drugs of Abuse Analysis Controls Industry Drivers
- 9.3 Drugs of Abuse Analysis Controls Industry Opportunities and Challenges
- 9.4 Drugs of Abuse Analysis Controls Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst